FT
TEVA icon

Fiduciary Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Fiduciary Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,846
Closed -$107K – 582
2020
Q3 		$107K Buy
11,846
+229
+2% +$2.42K ﹤0.01% 542
2020
Q2 		$143K Sell
11,617
-2
-0% -$23 ﹤0.01% 524
2020
Q1 		$104K Buy
+11,619
New +$119K ﹤0.01% 486
2017
Q4 		– Sell
-23,865
Closed -$421K – 445
2017
Q3 		$421K Sell
23,865
-36,997
-61% -$832K 0.01% 335
2017
Q2 		$2.02M Sell
60,862
-7,195
-11% -$223K 0.06% 189
2017
Q1 		$2.18M Sell
68,057
-12,818
-16% -$437K 0.07% 183
2016
Q4 		$2.93M Sell
80,875
-17,728
-18% -$708K 0.1% 160
2016
Q3 		$4.54M Sell
98,603
-1,700
-2% -$88.7K 0.16% 121
2016
Q2 		$5.04M Sell
100,303
-1,679
-2% -$89.4K 0.18% 113
2016
Q1 		$5.46M Buy
+101,982
New +$5.98M 0.19% 107

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Fiduciary Trust's TEVA Position: Q4 2020 in Review

Fiduciary Trust sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 11,846 shares — an estimated $107K sold.

Fiduciary Trust first reported a position in TEVA in Q1 2016 and held it in 10 quarters. The position peaked at $5.46M in Q1 2016. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Fiduciary Trust reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Fiduciary Trust sold 11,846 Teva Pharmaceuticals shares in Q4 2020, an estimated $107K.
  • Fiduciary Trust first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 10 quarters.
  • Fiduciary Trust's Teva Pharmaceuticals position peaked at $5.46M in Q1 2016.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Fiduciary Trust's 13F filing for Q4 2020, filed 26 Jan 2021.